These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 12117178)

  • 1. Can cancer centres in New Zealand help the cancer registry generate survival data? A pilot study in prostate cancer.
    Evans TK; Lamb DS; Cornes DA; Fraser J; Johnson CA; Hamilton DA
    N Z Med J; 2002 May; 115(1154):246-7. PubMed ID: 12117178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of New Zealand Cancer Registry data with an independent lung cancer audit.
    Stevens W; Stevens G; Kolbe J; Cox B
    N Z Med J; 2008 Jun; 121(1276):29-41. PubMed ID: 18574507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An audit of colon cancer data on the New Zealand Cancer Registry.
    Cunningham R; Sarfati D; Hill S; Kenwright D
    N Z Med J; 2008 Aug; 121(1279):46-56. PubMed ID: 18709047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial treatment patterns and outcome of contemporary prostate cancer patients with bone metastases at initial presentation: data from CaPSURE.
    Ryan CJ; Elkin EP; Cowan J; Carroll PR
    Cancer; 2007 Jul; 110(1):81-6. PubMed ID: 17516446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival in prostate carcinoma--outcomes from a prospective, population-based cohort of 8887 men with up to 15 years of follow-up: results from three countries in the population-based National Prostate Cancer Registry of Sweden.
    Aus G; Robinson D; Rosell J; Sandblom G; Varenhorst E;
    Cancer; 2005 Mar; 103(5):943-51. PubMed ID: 15651057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987.
    Jonsson E; Sigbjarnarson HP; Tomasson J; Benediktsdottir KR; Tryggvadottir L; Hrafnkelsson J; Olafsdottir EJ; Tulinius H; Jonasson JG
    Scand J Urol Nephrol; 2006; 40(4):265-71. PubMed ID: 16916765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy and completeness of the New Zealand Cancer Registry for staging of invasive breast cancer.
    Seneviratne S; Campbell I; Scott N; Shirley R; Peni T; Lawrenson R
    Cancer Epidemiol; 2014 Oct; 38(5):638-44. PubMed ID: 25037979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 13-year outcomes following treatment for clinically localized prostate cancer in a population based cohort.
    Albertsen PC; Hanley JA; Penson DF; Barrows G; Fine J
    J Urol; 2007 Mar; 177(3):932-6. PubMed ID: 17296379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prostate cancer diagnosed before 55: a retrospective study from the Rare Cancer Network].
    Nguyen TD; Poortmans PM; van der Hulst M; Studer G; Pigois E; Collen TD; Belkacemi Y; Beckendorf V; Miralbell R; Scandolaro L; Soete G; Villa S; Gez E; Thomas O; Krengli M; Saliou M;
    Bull Cancer; 2004 Dec; 91(12):959-64. PubMed ID: 15634636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer screening and disease management: how screening may have an unintended effect on survival and mortality-the camel's nose effect.
    Walsh RM; Thompson IM
    J Urol; 2007 Apr; 177(4):1303-6. PubMed ID: 17382719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short- and long-term mortality with localized prostate cancer.
    Merglen A; Schmidlin F; Fioretta G; Verkooijen HM; Rapiti E; Zanetti R; Miralbell R; Bouchardy C
    Arch Intern Med; 2007 Oct; 167(18):1944-50. PubMed ID: 17923593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer specific mortality in the Florence screening pilot study cohort 1992-1993.
    Ciatto S; Gervasi G; Gorini G; Lombardi C; Zappa M; Crocetti E
    Eur J Cancer; 2006 Aug; 42(12):1858-62. PubMed ID: 16829070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer--are ethnic minorities disadvantaged?
    Lamb DS; Bupha-Intr O; Bethwaite P; Murray J; Nacey J; Russell G; Delahunt B
    Anticancer Res; 2008; 28(6B):3891-5. PubMed ID: 19192646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood cancer registration in New Zealand: A registry collaboration to assess and improve data quality.
    Ballantine KR; Hanna S; Macfarlane S; Bradbeer P; Teague L; Hunter S; Cross S; Skeen J
    Cancer Epidemiol; 2018 Aug; 55():104-109. PubMed ID: 29902672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.
    Agalliu I; Weiss NS; Lin DW; Stanford JL
    Cancer Causes Control; 2007 Nov; 18(9):931-7. PubMed ID: 17641982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radical prostatectomy for clinical T4 prostate cancer.
    Johnstone PA; Ward KC; Goodman M; Assikis V; Petros JA
    Cancer; 2006 Jun; 106(12):2603-9. PubMed ID: 16700037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of short course hormonal therapy on overall and cancer specific survival after permanent prostate brachytherapy.
    Beyer DC; McKeough T; Thomas T
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1299-305. PubMed ID: 15817331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effectiveness of screening for prostate cancer: a nested case-control study.
    Concato J; Wells CK; Horwitz RI; Penson D; Fincke G; Berlowitz DR; Froehlich G; Blake D; Vickers MA; Gehr GA; Raheb NH; Sullivan G; Peduzzi P
    Arch Intern Med; 2006 Jan; 166(1):38-43. PubMed ID: 16401808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic features in men who died of prostate cancer.
    Thompson KE; Hernández J; Canby-Hagino ED; Troyer D; Thompson IM
    J Urol; 2005 Aug; 174(2):553-6; discussion 556. PubMed ID: 16006890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival rates of patients with prostate cancer in the prostate-specific antigen screening era: population-based estimates for the year 2000 by period analysis.
    Brenner H; Arndt V
    J Clin Oncol; 2005 Jan; 23(3):441-7. PubMed ID: 15572727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.